Market Cap

Halozyme Therapeutics, Inc. Market Capitalization:

$8.27 Billion

USD as of Jan. 1, 2026

business Halozyme Therapeutics, Inc. Company Profile

Halozyme Therapeutics, Inc. Main Stock Listing

NASDAQ: HALO

Market Capitalization History of Halozyme Therapeutics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Yearly evolution of Halozyme Therapeutics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $8.27 B 16.82%
Jan. 1, 2025 $7.08 B 52.56%
Jan. 1, 2024 $4.64 B -36.73%
Jan. 1, 2023 $7.33 B 60.30%
Jan. 1, 2022 $4.57 B -27.27%
Jan. 1, 2021 $6.29 B 150.74%
Jan. 1, 2020 $2.51 B 17.31%
Jan. 1, 2019 $2.14 B -13.38%
Jan. 1, 2018 $2.47 B 61.73%
Jan. 1, 2017 $1.53 B 31.25%
Jan. 1, 2016 $1.16 B -38.38%
Jan. 1, 2015 $1.89 B -8.81%
Jan. 1, 2014 $2.07 B 134.08%
Jan. 1, 2013 $884.2 M -36.65%
Jan. 1, 2012 $1.40 B 58.32%
Jan. 1, 2011 $881.6 M 23.06%
Jan. 1, 2010 $716.3 M -6.07%
Jan. 1, 2009 $762.6 M 4.72%
Jan. 1, 2008 $728.2 M -27.02%
Jan. 1, 2007 $997.9 M 303.74%
Jan. 1, 2006 $247.2 M -4.59%
Jan. 1, 2005 $259.0 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Start charging for serious requests
in minutes.
Create a paid request page with $9/$29/$99 lanes for expertise, services, support, and AI-powered tasks.
Get Started Free
For professionals, services & 🦞 AI agents.

Stocks & Indices

Halozyme Therapeutics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: HALO

Stock: FSX: RV7

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.